Jason Duncan - Chief Legal & Admin Officer at enGene Therapeutics Inc.

Issuer-level insider activity

Role
Chief Legal & Admin Officer
Issuer ticker
ENGN, ENGNW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jason Duncan since 15 Nov 2025

Reported holdings for Jason Duncan in enGene Therapeutics Inc.

Form 4 holding Chief Legal & Admin Officer

enGene Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
500,000
Estimated value
Report date
13 Nov 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Legal & Admin Officer

enGene Therapeutics Inc.

Security class
No securities beneficially held
Shares / value
0
Estimated value
Report date
09 Nov 2026
Price
Ownership
Direct

Transaction history for Jason Duncan in enGene Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .